Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 27.88%515.47M | -61.73%782.15M | -57.00%379.26M | -55.29%448.1M | -63.98%403.07M | -28.09%2.04B | -22.36%882M | 158.68%1B | 279.66%1.12B | 1,111.71%2.84B |
Transactional financial assets | -36.57%1.01B | 1,046.80%917.44M | 7.17%1.53B | 17.93%1.51B | 8.43%1.59B | --80M | -18.20%1.42B | --1.28B | --1.47B | ---- |
Notes receivable and accounts receivable | 105.05%340.59M | 85.07%310.59M | 14.47%233.95M | 40.43%190.45M | 7.24%166.11M | -15.18%167.82M | 7.73%204.38M | 9.54%135.62M | -33.21%154.9M | -0.39%197.85M |
-Notes receivable | -85.40%7.55M | -8.85%14.3M | 620.95%92.42M | 557.51%77.29M | 24.57%51.74M | -59.64%15.69M | 260.16%12.82M | 1.37%11.76M | 28.28%41.53M | 217.17%38.88M |
-Accounts receivable | 191.20%333.04M | 94.76%296.28M | -26.12%141.53M | -8.64%113.16M | 0.89%114.37M | -4.31%152.13M | 2.90%191.56M | 10.38%123.86M | -43.19%113.37M | -14.70%158.97M |
Other receivables (including interest and dividends) | -50.04%1.17M | 128.16%3.34M | 85.45%5.55M | 36.83%4M | -41.87%2.33M | -51.00%1.46M | 4.48%2.99M | 5.08%2.92M | 54.11%4.02M | 382.43%2.98M |
-Accrued interest receivable | ---- | --2.29M | --2.29M | --2.29M | --1.24M | ---- | ---- | ---- | ---- | ---- |
-Other receivable | ---- | -28.52%1.05M | ---- | -41.62%1.71M | ---- | -51.00%1.46M | ---- | 5.08%2.92M | ---- | 382.43%2.98M |
Advance payment | -54.05%5.64M | -49.32%4.03M | -65.13%4.86M | -33.03%5.05M | 147.93%12.26M | 401.32%7.94M | 40.94%13.95M | 60.67%7.53M | 1.22%4.95M | 36.51%1.58M |
Inventories | -10.15%98.78M | -19.04%87.07M | -29.03%79.24M | 19.34%102.37M | 38.96%109.94M | 37.53%107.54M | 48.77%111.65M | 0.22%85.78M | -10.23%79.12M | 28.50%78.2M |
Receivable financing | -64.09%55.29M | -71.91%52.67M | -67.68%32.75M | -70.02%53.2M | -1.24%153.99M | 119.27%187.48M | 30.52%101.32M | 39.53%177.46M | -24.33%155.92M | -76.31%85.5M |
Other current assets | 70.25%58.15M | 6.04%45.21M | 24.14%54.7M | -7.43%46.43M | -27.34%34.16M | 100.44%42.64M | 327.06%44.06M | 250.97%50.15M | 277.06%47.01M | 66.56%21.27M |
Total current assets | -15.69%2.08B | -16.53%2.2B | -16.81%2.32B | -13.95%2.36B | -18.46%2.47B | -18.29%2.64B | -14.12%2.78B | 267.66%2.74B | 260.37%3.03B | 271.43%3.23B |
Non Current assets | ||||||||||
Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --30.67M | --30.43M | ---- | ---- |
Other non-current financial assets | --5M | --5M | --5M | --5M | ---- | ---- | ---- | ---- | ---- | ---- |
Fixed assets | ---- | 15.66%1.26B | ---- | 220.82%1.19B | ---- | 175.35%1.09B | ---- | -10.60%371.44M | ---- | -10.14%395.9M |
Constru in process | ---- | 4.27%438.63M | ---- | -62.87%379.3M | ---- | -39.10%420.69M | ---- | 1,546.12%1.02B | ---- | 7,057.10%690.81M |
Intangible assets | 14.45%204.41M | 14.62%205.82M | 14.82%207.29M | 11.41%202.28M | -2.12%178.6M | 20.78%179.56M | 20.74%180.54M | 20.67%181.56M | 97.73%182.47M | 80.98%148.66M |
Long deferred expense | -14.17%543.39K | -13.22%590.73K | 252.76%646.07K | 167.22%701.42K | 85.21%633.09K | 61.64%680.72K | -64.19%183.15K | -61.17%262.48K | -59.33%341.82K | -58.10%421.15K |
Deferred tax assets | 179.54%55.68M | 192.58%48.23M | 315.18%40.82M | 203.93%30.07M | 125.95%19.92M | 67.63%16.49M | 79.67%9.83M | 81.64%9.89M | 43.50%8.82M | 80.31%9.83M |
Usufruct assets | -60.65%474.25K | -52.67%657K | -47.83%839.75K | -43.09%1.02M | -39.25%1.21M | -36.06%1.39M | -7.50%1.61M | -6.75%1.8M | -6.14%1.98M | -5.62%2.17M |
Other non current assets | 12.96%28.11M | -63.51%27.02M | 391.99%29.65M | 248.11%36.78M | -67.26%24.88M | 20.83%74.06M | -97.57%6.03M | -94.87%10.56M | -59.82%76M | -55.75%61.29M |
Total non current assets | 18.37%2.14B | 17.09%2.09B | 13.18%1.9B | 17.26%1.91B | 22.73%1.81B | 36.20%1.78B | 66.20%1.68B | 93.27%1.63B | 99.89%1.48B | 92.62%1.31B |
Total assets | -1.29%4.23B | -2.98%4.29B | -5.53%4.22B | -2.33%4.27B | -4.97%4.28B | -2.58%4.42B | 4.96%4.46B | 175.17%4.37B | 185.36%4.51B | 192.99%4.54B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | --3.44M | --3.44M | --3.44M | --3.46M | ---- | ---- | ---- | ---- |
Transactional financial liabilities | --116.88K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Notes payable and accounts payable | 37.31%395.25M | 20.23%452.04M | -17.86%305.81M | 11.31%322.48M | -22.83%287.86M | -14.49%375.99M | 60.22%372.31M | 95.18%289.72M | 176.58%373.02M | 177.33%439.71M |
-Notes payable | 83.82%228.05M | 20.33%186.34M | -5.57%159.23M | 16.38%125.28M | -45.54%124.06M | -46.33%154.86M | -4.80%168.61M | -2.85%107.64M | 193.84%227.82M | 190.07%288.52M |
-Accounts payable | 2.08%167.2M | 20.15%265.7M | -28.04%146.58M | 8.31%197.21M | 12.81%163.8M | 46.26%221.13M | 268.58%203.7M | 383.66%182.08M | 153.24%145.2M | 155.86%151.19M |
Contract liabilities | -60.06%215.07K | 443.44%204.87K | 173.06%212.65K | 449.41%184.76K | 1,468.30%538.5K | 12.11%37.7K | -79.72%77.88K | -99.73%33.63K | -99.89%34.34K | -99.96%33.63K |
Salaries payable | 2.49%13.98M | -0.39%21.88M | -6.01%18.29M | -1.26%17.22M | 6.31%13.64M | -8.66%21.97M | -51.65%19.46M | -44.41%17.44M | -38.80%12.83M | -2.98%24.05M |
Taxs payable | -56.35%2.31M | 9.98%4.03M | 77.45%2.8M | -47.86%2.18M | -60.11%5.29M | -80.74%3.66M | -81.62%1.58M | -69.66%4.18M | -73.51%13.26M | -53.41%19.02M |
Other payable (including interest and dividends) | -7.26%198.04K | 4.08%203.81K | -94.04%47.54K | 274.13%200.22K | 304.51%213.54K | 270.95%195.82K | 8,862.29%797.64K | 198.97%53.52K | -14.57%52.79K | 6.03%52.79K |
-Other payable | ---- | 4.08%203.81K | ---- | 274.13%200.22K | ---- | 270.95%195.82K | ---- | 198.97%53.52K | ---- | 6.03%52.79K |
Non current liabilities due within one year | 306.70%6.45M | 302.56%6.31M | 11.18%1.33M | 43.93%1.28M | 115.66%1.58M | 86.62%1.57M | 54.44%1.2M | 19.87%889.73K | 1.64%734.85K | 18.96%839.5K |
Other current liabilities | -36.51%7.47M | -61.39%15.49M | -73.65%11.28M | -83.80%9.7M | -62.25%11.77M | 176.68%40.13M | 1,312.16%42.8M | 794.49%59.86M | 72.97%31.18M | -46.83%14.5M |
Total current liabilities | 31.34%425.99M | 11.89%500.16M | -21.68%343.21M | -4.16%356.69M | -24.77%324.35M | -10.27%447.02M | 51.16%438.22M | 33.62%372.18M | 34.47%431.11M | 5.98%498.21M |
Current liabilities | ||||||||||
Deferred tax liabilities | --53.78K | --53.78K | ---- | ---- | ---- | ---- | 3,628.82%2.07M | --1.19M | --119.65K | --119.65K |
Long term deferred income | -15.77%22.68M | -14.33%23.93M | -14.31%24.93M | -13.37%25.93M | -12.47%26.93M | -11.63%27.93M | 7.50%29.1M | 55.36%29.93M | 51.68%30.77M | 57.39%31.6M |
Lease liabilities | ---- | ---- | ---- | -77.10%235.97K | -77.66%233.83K | -63.85%467.67K | -51.92%581.59K | -16.03%1.03M | -14.81%1.05M | -11.68%1.29M |
Other non current liabilities | 0.00%30.2M | 0.00%30.2M | 11.44%30.2M | --30.2M | --30.2M | --30.2M | --27.1M | ---- | ---- | ---- |
Total non current liabilities | 70.29%307.3M | 22.97%223.43M | 21.68%213.23M | 29.33%189.47M | 45.14%180.46M | 68.21%181.7M | 172.41%175.25M | 614.84%146.5M | 477.92%124.33M | 401.38%108.02M |
Total liabilities | 45.26%733.3M | 15.09%723.59M | -9.30%556.45M | 5.30%546.16M | -9.12%504.81M | 3.71%628.71M | 73.18%613.47M | 73.46%518.68M | 62.35%555.45M | 23.31%606.22M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%159.5M | 0.00%159.5M | 0.00%159.5M | 0.00%159.5M | 45.00%159.5M | 45.00%159.5M | 45.00%159.5M | 94.51%159.5M | 34.15%110M | 34.15%110M |
Capital reserve funds | 0.14%2.91B | 0.10%2.91B | 0.03%2.91B | -0.00%2.9B | -1.68%2.9B | -1.68%2.9B | -1.68%2.9B | 605.45%2.9B | 623.51%2.95B | 629.65%2.95B |
Surplus reserve funds | 0.00%63.06M | 0.00%63.06M | 14.65%63.06M | 14.65%63.06M | 14.65%63.06M | 14.65%63.06M | 19.96%55M | 19.96%55M | 19.96%55M | 19.96%55M |
Retained profit | -43.65%325.63M | -37.58%368.71M | -29.20%458.97M | -19.33%518.14M | -22.29%577.86M | -19.38%590.67M | -8.27%648.26M | -5.87%642.29M | 17.27%743.62M | 52.32%732.64M |
Less:Treasury stock | 190.04%78.08M | 403.34%50.32M | 275.02%30M | --30M | --26.92M | --10M | --8M | ---- | ---- | ---- |
Specific reserves | -12.04%18.42M | -8.35%19.34M | -7.45%19.33M | -8.60%19.31M | -2.28%20.94M | 4.43%21.1M | 9.31%20.88M | 20.12%21.13M | 31.54%21.43M | 39.00%20.2M |
Shareholders equity without minority interests | -8.16%3.4B | -7.00%3.47B | -5.40%3.58B | -3.91%3.63B | -4.77%3.7B | -3.70%3.73B | -1.45%3.78B | 205.17%3.78B | 227.35%3.88B | 276.57%3.87B |
Minority interests | 23.56%95.5M | 53.89%98.76M | 20.75%83.93M | 27.73%87.06M | 17.95%77.29M | 6.15%64.18M | 11.70%69.51M | 38.11%68.16M | 30.85%65.53M | 106.62%60.46M |
Total shareholder equity | -7.51%3.49B | -5.97%3.57B | -4.92%3.66B | -3.35%3.72B | -4.39%3.78B | -3.55%3.79B | -1.24%3.85B | 198.77%3.85B | 219.39%3.95B | 271.87%3.93B |
Total liabilityies and equity | -1.29%4.23B | -2.98%4.29B | -5.53%4.22B | -2.33%4.27B | -4.97%4.28B | -2.58%4.42B | 4.96%4.46B | 175.17%4.37B | 185.36%4.51B | 192.99%4.54B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.